DeuteRx Celebrates Women's History Month with Over a Decade of Pioneering Leadership in Drug Discovery [Yahoo! Finance]
Decoy Therapeutics Inc. (DCOY)
Company Research
Source: Yahoo! Finance
BOSTON March 31, 2026 /PRNewswire/ -- In honor of Women's History Month, DeuteRx, LLC celebrates women and women-led companies driving leadership, growth and cultures of respect with long-term success. DeuteRx today issues a State of the Union update on the scientific contributions and executive leadership of Sheila DeWitt, PhD, Chair, President, and CEO, whose work has advanced and redefined pharmaceutical innovation for more than three decades. DeuteRx, LLC (PRNewsfoto/DeuteRx LLC) DeuteRx State of the Union Update 2025–2026: Industry recognition for scientific and executive leadership 2012–2025: M&A transactions for metabolic, cancer, and psychiatric disorders 2010–2012: Innovation and validation of novel R&D platform A Pioneer in Deuterated Drug Discovery Dr. DeWitt invented Deuterium-Enabled Chiral Switching (DECS) in 2010, a novel strategy to stabilize interconverting stereoisomers in racemic drugs to facilitate development of the preferred stereoisomers and creat
Show less
Read more
Impact Snapshot
Event Time:
DCOY
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
DCOY alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
DCOY alerts
High impacting Decoy Therapeutics Inc. news events
Weekly update
A roundup of the hottest topics
DCOY
News
- Decoy Therapeutics Builds Momentum with Accelerating Execution, Entering a Highly Catalytic Phase with a Clearly Defined Path to Clinical Development of its Antiviral Pipeline [TheStreet.com]TheStreet.com
- Decoy Therapeutics Builds Momentum with Accelerating Execution, Entering a Highly Catalytic Phase with a Clearly Defined Path to Clinical Development of its Antiviral PipelinePR Newswire
- Decoy Therapeutics to Participate in Virtual Investor Closing Bell Event Highlighting Business Outlook for 2026 [Yahoo! Finance]Yahoo! Finance
- Decoy Therapeutics to Participate in Virtual Investor Closing Bell Event Highlighting Business Outlook for 2026 [TheStreet.com]TheStreet.com
- Decoy Therapeutics to Participate in Virtual Investor Closing Bell Event Highlighting Business Outlook for 2026PR Newswire
DCOY
Sec Filings
- 4/2/26 - Form S-8
- 4/2/26 - Form 8-K
- 3/31/26 - Form 10-K
- DCOY's page on the SEC website